Abstract
Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 206-211 |
| Number of pages | 6 |
| Journal | Current Drug Targets |
| Volume | 12 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jul 2012 |
Keywords
- Age-related macular degeneration
- AntiVEGF
- Choroidal neovascularization
- Combination therapy
- Photodynamic therapy
- Polypoidal choroidal vasculopathy
- Triamcinolone
ASJC Scopus subject areas
- Drug Discovery
- Pharmacology
- Clinical Biochemistry
- Molecular Medicine
Fingerprint Dive into the research topics of 'Polypoidal Choroidal Vasculopathy: Recent advances in therapy'. Together they form a unique fingerprint.
Cite this
de Crecchio, G., Chan, R. V. P., Manzi, G., & Romano, M. R. (2012). Polypoidal Choroidal Vasculopathy: Recent advances in therapy. Current Drug Targets, 12(2), 206-211. https://doi.org/10.2174/138945011794182782